gip/glp-1 agonist GLP-1 & GIP Agonists | Obesity and Diabetes Management | Harrison's updates (22nd Ed.) GLP1-GIP receptor co-agonists: a promising
Description
JAMA Pediatr (2022) 176(5):45260
Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db mice
Astrup A, Carraro R, Finer N, Harper A, Kunesova M, Lean ME, et al
Some analyses from these trials showed modest reductions in inflammatory biomarkers, including high-sensitivity C-reactive protein (hs-CRP)
FinanBClemmensenCZhuZStemmerKGauthierKMllerLet al
Ali T, Hasan M, Hamadani M, Harty RF
